Diplopia After Coronary Revascularization

Authors

  • Joana Braga Ophthalmology Department. Centro Hospitalar Vila Nova de Gaia / Espinho. Vila Nova de Gaia. https://orcid.org/0000-0002-2654-4626
  • Filipe Neves Ophthalmology Department. Centro Hospitalar Vila Nova de Gaia / Espinho. Vila Nova de Gaia.
  • João Costa Ophthalmology Department. Centro Hospitalar Vila Nova de Gaia / Espinho. Vila Nova de Gaia.
  • Dália Meira Ophthalmology Department. Centro Hospitalar Vila Nova de Gaia / Espinho. Vila Nova de Gaia.

DOI:

https://doi.org/10.20344/amp.11751

Keywords:

Diplopia, Myocardial Revascularization, Ocular Motility Disorders, Percutaneous Coronary Intervention

Abstract

Percutaneous coronary intervention is a coronary revascularization procedure that may rarely result in thromboembolic events. Although infrequent, ophthalmological complications of percutaneous interventions include a wide range of clinical presentations, with differing severity and outcomes. In this case report, an 83-year-old woman, with multiple cardiovascular risk factors, presents with horizontal diplopia after a percutaneous transluminal coronary angioplasty. After ophthalmological evaluation and a head computed tomography scan, the diagnosis of isolated ischemic internuclear ophthalmoplegia was established. After six months of follow-up, the patient showed complete recovery of her symptoms and ocular movements. We discuss the post-percutaneous intervention ophthalmic complications that, although uncommon, must be recognized by health care providers.

Downloads

Download data is not yet available.

Downloads

Published

2020-10-01

How to Cite

1.
Braga J, Neves F, Costa J, Meira D. Diplopia After Coronary Revascularization. Acta Med Port [Internet]. 2020 Oct. 1 [cited 2024 Nov. 22];33(10):685-8. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/11751

Issue

Vol. 33 No. 10 (2020): October

Section

Case Report

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC